Skip to content
DraconiticResearch
Search Sources API
190,869 studies31 sourcesUpdated 20 min ago
PreprintCC BYbioRxiv

Branch-Wise Regularization for Heterogeneous GNN-Based MALDI-TOF AMR Prediction with Biomarker-Consensus Edges

  1. 1National Chung Hsing University

Abstract

This paper predicts antimicrobial resistance (AMR) from matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectra using DRIAMS, evaluated across 13 species-antibiotic datasets spanning sensitive/resistant imbalance ratios of 2.95:1 to 141.21:1 and raw spectral similarities of 0.9166-0.9946. We propose HetSAGE, a heterogeneous graph neural network (GNN) that combines full-spectrum "raw" edges with consensus "biomarker" edges derived from a 4-method feature-selection vote and applies per-edge-type dropout to regularize the two views separately. HetSAGE outperforms a plain multilayer perceptron (MLP) only when spectral similarity is high, consistent with oversmoothing effects reported in the broader GNN literature; the biomarker view converges on features close to independently established clinical markers: within {+/-}1 Da in Staphylococcus aureus, Oxacillin, and within range in Klebsiella pneumoniae, Meropenem, confirming it is not a black box. At the same time, per-edge-type dropout protects this smaller signal from dilution by regularization tuned for the noisier raw spectrum. Together, these results indicate that heterogeneous graph structure is not a universal win for MALDI-TOF AMR prediction but a conditional one, tied to a measurable property of the data, spectral similarity, rather than to architecture alone. This caveat is largely unaddressed in current DRIAMS-based GNN work. It provides a concrete signal for practitioners deciding when a graph model is worth the added complexity over a plain MLP.

Related

  1. MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models
    Robert Moore, Frank Agayie-Ntim, Lindsey B. Crawford +5
    arXivPreprintCC BY-SA 4.0Full textGeneral biologyarXiv
  2. Heterogeneous Graph Contrastive Learning for Drug-Gene-Disease Motif Prediction
    H. Xie, Y. Gao, S. Ke +1
    bioRxivPreprintCC BYFull textBioinformatics & computational biologybioRxiv
  3. Mechanical characterization of glioblastoma cell – substrate interaction by fading regularization method
    Noé Bourgeois, Hatem Zayeni, Aurélie Gangneux +5
    Multidisciplinary Biomechanics JournalPeer-reviewedCC BY 4.0Full textCell biologyHAL
  4. Reflections on the ESC consensus statement on inflammation in coronary syndromes: From mechanistic certainty to practical cardiology
    François Roubille, Mark Nidorf, Jean-Claude Tardif
    Archives of cardiovascular diseasesPeer-reviewedCC BYImmunologyHAL
  5. The Management of Type 1 Diabetes in Adults. The Updated 2026 Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Richard I.G. Holt, J. Hans Devries, Amy Hess-Fischl +11
    Diabetes CarePeer-reviewedLicence not statedFull text1 citedGeneral biologyEndocrinology & metabolismHAL
BibTeX
@misc{tsai2026branchwise,
  title = {{Branch-Wise Regularization for Heterogeneous GNN-Based MALDI-TOF AMR Prediction with Biomarker-Consensus Edges}},
  author = {W.-Y. Tsai and Y.- T. Shih and Y.- H. Chen},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.24.754085},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.24.754085v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Branch-Wise Regularization for Heterogeneous GNN-Based MALDI-TOF AMR Prediction with Biomarker-Consensus Edges
AU  - W.-Y. Tsai
AU  - Y.- T. Shih
AU  - Y.- H. Chen
PY  - 2026
DA  - 2026/09/24
PB  - bioRxiv
DO  - 10.64898/2026.09.24.754085
UR  - https://www.biorxiv.org/content/10.64898/2026.09.24.754085v1
AB  - This paper predicts antimicrobial resistance (AMR) from matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectra using DRIAMS, evaluated across 13 species-antibiotic datasets spanning sensitive/resistant imbalance ratios of 2.95:1 to 141.21:1 and raw spectral similarities of 0.9166-0.9946. We propose HetSAGE, a heterogeneous graph neural network (GNN) that combines full-spectrum "raw" edges with consensus "biomarker" edges derived from a 4-method feature-selection vote and applies per-edge-type dropout to regularize the two views separately. HetSAGE outperforms a plain multilayer perceptron (MLP) only when spectral similarity is high, consistent with oversmoothing effects reported in the broader GNN literature; the biomarker view converges on features close to independently established clinical markers: within {+/-}1 Da in Staphylococcus aureus, Oxacillin, and within range in Klebsiella pneumoniae, Meropenem, confirming it is not a black box. At the same time, per-edge-type dropout protects this smaller signal from dilution by regularization tuned for the noisier raw spectrum. Together, these results indicate that heterogeneous graph structure is not a universal win for MALDI-TOF AMR prediction but a conditional one, tied to a measurable property of the data, spectral similarity, rather than to architecture alone. This caveat is largely unaddressed in current DRIAMS-based GNN work. It provides a concrete signal for practitioners deciding when a graph model is worth the added complexity over a plain MLP.
ER  -